Catalyst Wire Dossier Catalyst Wire Dossier

INNA-051

· ENA Respiratory Pty Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for INNA-051, covering 2023-01-18 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age [Phase 2]

See pricing